The Association of Diabetes Investigators

Dr rendell is section editor for endocrinology for annals of medicine as such overviewing contributions pertinent to our purpose

Dr rendell has published comments on important health questions related to Diabetes and obesity notably rendell m exploring possible limitations of The grade trial findings about renal outcomes of liraglutide comment on wexler dj de boer ih ghosh a et al. Comparative effects of glucose-lowering medications on kidney outcomes in type 2 Diabetes: The grade randomized clinical trial. Jama intern med. Published online may 22 2023. doi:10.1001 jamainternmed.2023.1487 rendell m The economics of new agents to combat obesity comment on wright et al a prescription for achieving equitable access to antiobesity medications. Jama health forum. 2023 44e230493. Doi0.1001jamahealthforum.2023.0493 rendell m were alternatives fully discussed? No mention of suppression of tsh? Comment on sawka am ghai s rotstein l et al. Gender differences in fears related to low-risk papillary thyroid cancer and its treatment. Jama otolaryngol head neck surg. Published online july 06 2023. doi:10.1001 jam

Dr rendell is an active reviewer for annals of internal medicine Diabetes care Diabetes obesity and metabolism dove press and The expert review series from taylor francis. In year 2023 79 manuscripts were reviewed and recommendations submitted to The journals.